Ridley Medical Research Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.95 M
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
- Revenue Growth %
- Profit Growth 24.56%
- Ebitda 97.34%
- Net Worth -406.53%
- Total Assets -31.71%
About Ridley Medical Research
Ridley Medical Research Private Limited (RMRPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 June 2014 and has a history of Ten years and seven months. Its registered office is in Varanasi, Uttar Pradesh, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.95 M.
The company currently has active open charges totaling ₹5.00 M.
Sakshi Singh and Gaurav Singh serve as directors at the Company.
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74999UP2014PTC064398
- Company No.
064398
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jun 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Ridley Medical Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sakshi Singh  | Director | 04-Mar-2021 | Current |
| Gaurav Singh | Director | 19-Jun-2014 | Current |
Financial Performance of Ridley Medical Research.
Ridley Medical Research Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 24.56% increase in profit. The company's net worth observed a substantial decline by a decrease of 406.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ridley Medical Research?
In 2017, Ridley Medical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Morus Lifescience Private LimitedSakshi Singh and Gaurav Singh are mutual person
- Morus Infra (Opc) Private Limited
Gaurav Singh is a mutual person
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Mar 2017 | Bank Of India | ₹5.00 M | Open |
How Many Employees Work at Ridley Medical Research?
Unlock and access historical data on people associated with Ridley Medical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ridley Medical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ridley Medical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
